SIGN UP FOR BREAKING NEWS

FDA notes shortages of 2 drugs after they were touted by President Trump

Share

Shares

Copy Link

{copyShortcut} to copy
Link copied!

Updated: 6:09 PM CDT Apr 1, 2020

Hide TranscriptShow Transcript

hydroxy florid point is probably a drug you've heard a lot about lately. President Trump recently mentioned it as a possible treatment for Covert 19. Even the doctors say there's no evidence it works on Corona virus patients. The FDA is now announcing a shortage of that drug, plus Laura Quinn. It posted that information. It's drug shortages. Web page. The FDA says there's a significant surge in demand, making it difficult for people who need the medication from getting it. Those drugs were used to treat malaria, Lupus and rheumatoid arthritis manufacturers Air now ramping up production. The FDA is announcing this shortage just a couple of days after giving the green light hospitals across the country to use this drug on seriously ill Corona virus patients saying is worth the risk despite the lack of clinical trials in Washington on my accidents.

Advertisement

FDA notes shortages of 2 drugs after they were touted by President Trump

The FDA says it has shortages of two drugs that have gained a lot of attention in recent weeks. Hydroxychloroquine is a drug you've probably heard a lot about lately. President Donald Trump mentioned it as a possible treatment for COVID-19, even though doctors say there's no evidence it works on coronavirus patients. Now the Food and Drug Administration says there's a shortage of that drug and chloroquine.It posted that information on its drug shortages webpage. The FDA says there's a significant surge in demand, making it difficult for people who need the medication to get it. The drugs are used to treat malaria, lupus and rheumatoid arthritis.Manufacturers are now ramping up production.The federal agency is announcing this shortage just a couple of days after giving the green light to hospitals across the country to use the drug on coronavirus patients who are seriously ill, saying it's worth the risk to try it — despite the lack of clinical trials.

The FDA says it has shortages of two drugs that have gained a lot of attention in recent weeks.

Hydroxychloroquine is a drug you've probably heard a lot about lately. President Donald Trump mentioned it as a possible treatment for COVID-19, even though doctors say there's no evidence it works on coronavirus patients.

Advertisement

Now the Food and Drug Administration says there's a shortage of that drug and chloroquine.

It posted that information on its drug shortages webpage. The FDA says there's a significant surge in demand, making it difficult for people who need the medication to get it.

The drugs are used to treat malaria, lupus and rheumatoid arthritis.

Manufacturers are now ramping up production.

The federal agency is announcing this shortage just a couple of days after giving the green light to hospitals across the country to use the drug on coronavirus patients who are seriously ill, saying it's worth the risk to try it — despite the lack of clinical trials.